Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
5 Nov 2026Somnum Pharma Inc.United StatesA Study of Oral SOM001 as a Safe and Effective Treatment for Adults With Chronic InsomniaPhase 2Not Yet Recruiting5 Nov 2026Suzhou HepaThera Biotech Co., Ltd.A Study of HT-101 and HT-102 in Chronic Hepatitis B (CHB)Phase 2Not Yet Recruiting5 Nov 2026Teva Branded Pharmaceutical Products R&D LLCTwo Trials to Evaluate TEV-53408 in Participants With Non-Segmental VitiligoPhase 2, Phase 3Not Yet Recruiting4 Nov 2026Antlia Bioscience, IncNew ZealandStudy of AB-110 in Healthy and Hypertensive ParticipantsPhase 1Not Yet Recruiting4 Nov 2026Arcutis Biotherapeutics, Inc.United StatesRoflumilast Cream 0.3% for Moderate to Severe Atopic DermatitisPhase 3Recruiting4 Nov 2026Ascendis Pharma A/SA Clinical Trial to Evaluate Efficacy and Safety of Navepegritide Versus Placebo in Children and Adolescents With HypochondroplasiaPhase 3Not Yet Recruiting4 Nov 2026AstraZenecaBreast Cancer Real-World Insights and Decision Guidance Evaluation in Hong KongNot Yet Recruiting4 Nov 2026AstraZenecaA Study to Screen for Lung Cancer in High-risk Individuals Who Have Never Smoked Using Low-dose Computed Tomography (LDCT).Not Yet Recruiting4 Nov 2026AstraZenecaTreatment Pattern and Patient Outcomes Among Stage I-II Unresected NSCLC PatientsNot Yet Recruiting4 Nov 2026Basilea PharmaceuticaUnited StatesA Study to Test the Safety of the Study Drug Fosmanogepix and How the Body Handles It in Adults With Severe Kidney Failure on DialysisPhase 1Recruiting4 Nov 2026Beijing Gene Key Life Technology Co., LtdChinaA Study of GKL-006Allo Injection in Patients With Ankylosing SpondylitisPhase 1Not Yet Recruiting4 Nov 2026Beijing QL Biopharmaceutical Co.,LtdChinaA Study of Zovaglutide (ZT002 Injection) in Participants With Hepatic Impairment and Healthy ParticipantsPhase 1Not Yet Recruiting4 Nov 2026Boehringer IngelheimUnited States, Argentina, AustriaA Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Phase 3Not Yet Recruiting4 Nov 2026Capstan MedicalUnited StatesEarly Feasibility Study of the Capstan Medical TMVR SystemNot applicableRecruiting4 Nov 2026Colgate PalmoliveDominican RepublicEfficacy of Two Brushing Regimens in the Reduction of Established Dental Plaque and GingivitisPhase 3Completed4 Nov 2026Eli Lilly and CompanySingaporeA Study of Lepodisiran (LY3819469) in Participants With High Lipoprotein(a)Phase 1Recruiting4 Nov 2026Eli Lilly and CompanyUnited States, SingaporeA Study of LY4247147 in Participants With Obesity or Overweight Who Are Otherwise HealthyPhase 1Recruiting4 Nov 2026Genfleet Therapeutics (Shanghai) Inc.A Phase Ib/II Study of GFH276 in Combination With Chemotherapy (± Bevacizumab) or Cetuximab in Patients With RAS-mutant Metastatic Colorectal CancerPhase 1, Phase 2Not Yet Recruiting4 Nov 2026GlaxoSmithKlineUnited States, United KingdomA Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)Phase 2Recruiting4 Nov 2026Haisco Pharmaceutical Group Co., Ltd.ChinaPhase 1 Study to Assess the Effects of HSK31858 on the QT/QTc Interval in Healthy Chinese ParticipantsPhase 1Recruiting4 Nov 2026Haisco Pharmaceutical Group Co., Ltd.ChinaInvestigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Renal ImpairmentPhase 1Recruiting4 Nov 2026Innovent Biologics (Suzhou) Co. Ltd.ChinaSintilimab Combined With LCCRT Followed by Capeox Chemotherapy in pMMR/MSS/MSI-L Locally Advanced Rectal CancerPhase 3Not Yet Recruiting4 Nov 2026InnovStone Therapeutics LimitedChinaSYH2072 Tablets in Participants With Primary AldosteronismPhase 2Not Yet Recruiting4 Nov 2026Janssen Research & Development, LLCA Study to Assess Pregnancy, Neonatal and Infant Outcomes in Participants Exposed to NipocalimabNot Yet Recruiting4 Nov 2026Latigo BiotherapeuticsLTG-321 - Itraconazole Drug-drug Interaction (DDI) StudyPhase 1Not Yet Recruiting4 Nov 2026Luminance Biosciences IncAustraliaSafety and Biodistribution of [68Ga]Ga DOTA-5G in Subjects With Metastatic Breast Cancer (BC)Phase 1Not Yet Recruiting4 Nov 2026Össur Iceland ehfUnited StatesHand Prosthesis Usability and PerformanceNot applicableRecruiting4 Nov 2026PfizerUnited StatesA Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)Phase 3Recruiting4 Nov 2026REMD Medical TechnologyChinaA Study of the Safety and Effectiveness of a Compound Steep-Pulse Therapy Apparatus for Malignant Liver TumorsNot applicableCompleted4 Nov 2026Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.ChinaA Study of Efficacy and Safety of FXS6837 in Anti-C5 Treated PNH Patients.Phase 3Not Yet Recruiting4 Nov 2026Shanghai Qilu Pharmaceutical Research and Development Center LTDA Study of QLS5314 Monotherapy in Participants With Advanced Solid TumorsPhase 1Not Yet Recruiting4 Nov 2026Teleon Surgical B.V.Safety and Clinical Performance of the LENTIS® MAX LS-313 MF80 Compared With the Monofocal L-313 in Cataract Patients With Late Age-Related Macular Degeneration: A Multicenter Comparative Clinical Investigation.Not applicableNot Yet Recruiting4 Nov 2026Vexev Pty LtdAustraliaComparison of VxWave and Standard Ultrasound Measurements of Blood Vessels in the ArmNot applicableNot Yet Recruiting4 Nov 2026Xintian PharmaceuticalA Study on the Efficacy and Safety of Ningmitai Capsules in Treating Patients With Upper Urinary Tract Stones After Extracorporeal Shock Wave LithotripsyPhase 4Not Yet Recruiting3 Nov 2026Antev Ltd.PRECISION-E2: Teverelix in Women With Endometriosis - Pharmacodynamics, Safety and Precision Medicine CorrelatesPhase 2Not Yet Recruiting3 Nov 2026Arjil Pharmaceuticals LLCTaiwanA Study for AR100DP1 in Mild to Moderate Atopic DermatitisPhase 2Recruiting3 Nov 2026Beijing InnoCare Pharma Tech Co., Ltd.Safety, Tolerability and Pharmacokinetics of ICP-B161 in Healthy Adults VolunteersPhase 1Not Yet Recruiting3 Nov 2026Beijing Mabworks Biotech Co., Ltd.A Study of MBS314 for Injection in Participants With Relapsed/Refractory Multiple Myeloma.Phase 1, Phase 2Not Yet Recruiting3 Nov 2026Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.ChinaStudy of YKYY032 Injection in Adults With Hyperlipoproteinemia (a)Phase 2Not Yet Recruiting3 Nov 2026BeOne MedicinesStudy Evaluating the Efficacy and Safety of BGB-B2033 in Participants With Advanced Hepatocellular CarcinomaPhase 2Not Yet Recruiting3 Nov 2026COSMEDICIAN AP SDN BHDMalaysiaPilot Study of Combination Treatment With Subcision, Human Adipose Tissue-Derived Exosomes and Powdered Polydioxanone for Atrophic Acne ScarsNot applicableCompleted3 Nov 2026Coultreon BiopharmaCanadaA Study to Assess the Safety and Effectiveness of COL-5671-PRO Capsules in Adults With Moderate-to-Severe Plaque PsoriasisPhase 2Not Yet Recruiting3 Nov 2026CSPC ZhongQi Pharmaceutical Technology Co., Ltd.ChinaA Study of SYH2051 in Combination With Irinotecan Hydrochloride Liposome Injection in Subjects With Advanced Solid TumorsPhase 1, Phase 2Not Yet Recruiting3 Nov 2026Ensem TherapeuticsUnited StatesA KRAS Inhibitor in Participants With Advanced Solid TumorsPhase 1, Phase 2Recruiting3 Nov 2026Genfleet Therapeutics (Shanghai) Inc.GFH375 Plus Cetuximab vs Investigator's Choice of Treatment in KRAS G12D-Mutant Refractory Metastatic Colorectal CancerPhase 3Not Yet Recruiting3 Nov 2026Gilead SciencesStudy to Compare GS-1179 Versus Valacyclovir in HSV-2 Seropositive Participants With Recurrent Genital HerpesPhase 2Not Yet Recruiting3 Nov 2026Grünenthal GmbHA Trial to Investigate the Efficacy and Safety of Tegacorat in Male Participants 4 to <7 Years of Age With Duchenne Muscular DystrophyPhase 2Not Yet Recruiting3 Nov 2026Haisco Pharmaceutical Group Co., Ltd.ChinaInvestigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Hepatic ImpairmentPhase 1Recruiting3 Nov 2026Human Biome S.A.Fecal Microbiota Transplantation (FMT) to Slow Biological AgingNot applicableNot Yet Recruiting3 Nov 2026Hunan Kelun Pharmaceutical Co., Ltd.ChinaA Study to Evaluate the PK/PD and Safety of KL0011034 Injection in Healthy Non-Elderly and Elderly Trial ParticipantsPhase 1Not Yet Recruiting// How AOS uses this